FDA Publishes New Filing Checklists to Prevent Drug Submission Delays on October 24, 2025 Abbreviated New Drug Application Complete Response Letters drug application filing checklist New Drug Application regulatory guidance submission delays United States Food and Drug Administration +
FDA Launches New Submission Program for Rare Disease Gene Therapies via CDER and CBER on September 04, 2025 Accelerated Approved CBER CDER gene therapy Hereditary Diseases Infrequent RDEP regulatory guidance submission program United States Food and Drug Administration +
Rethinking Clinical Trial Data in the Era of Decentralization: Key Trends and Challenges (2025) on July 28, 2025 Artificial Intelligence Clinical Trials data integration Data Quality DCT gene decentralized Diversity Preventive monitoring regulatory guidance Remote risk-based oversight trials +